A couple of fresh studies led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and published in the journal Science help shine some light on two critical questions, including whether vaccines will prevent infection with COVID-19 and does contracting the...
Beth Israel Deaconess Medical Center (BIDMC), part of Beth Israel Lahey Health, has completed a clinical trial that identified four novel prototypes of 3D-printed swabs that can be used for COVID-19 testing. An important step to overcome a shortage of specialized...
Beth Israel Deaconess Medical Center (BIDMC) investigators are enrolling patients in two clinical trials targeting COVID-19. The two trial are led by Kathryn Stephenson, MD, MPH, an infectious disease specialist, and the team will test Gilead’s remdesivir (an...
Beth Israel Deaconess Medical Center (BIDMC) inked a collaborative deal with Johnson & Johnson’s Janssen Pharmaceutical Co to develop a preventive vaccine candidate for COVID-19. One of the world’s elite biopharmaceutical ventures and the preeminent academic...
Investigators from Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center have conducted the largest prospective study using objective measures of sleep to date to evaluate the relationship between sleep and migraine headaches. They found that...
Beth Israel Deaconess Medical Center (BIDMC) and their Cancer Center are actively participating to support patients during National Prostate Month. Their Prostate Cancer Program has several expert sources to drive progress in the fight against prostate cancer....
